Tapentadol is partly metabolized from the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that greatly enhance or repress the exercise/expression of one or more of these enzymes, as well as with substrates of such enzymes (due to competition for your enzyme); some enzyme mediators/substrates https://samuelx220dgs6.mybuzzblog.com/profile